Brain Tumour Conference: Programme

Brain 2020 conference hero image

Brain Tumour Conference 2020

CORONAVIRUS INFORMATION: CANCER RESEARCH UK EVENTS 

Last updated 13 March, 2020

Important information regarding your registration at the Brain Tumour Conference 2020

Cancer Research UK have been closely monitoring developments relating to the coronavirus (COVID-19) outbreak and reviewing guidance from government bodies.  After careful consideration we have taken the decision not to go ahead as planned, with the Brain Tumour Conference scheduled for 12-14 May 2020.

With the number of attendees, including those travelling internationally, and given that many of you work with vulnerable communities, we agreed that safeguarding your health and safety, and the health and safety of those you work with, is our priority. With global restrictions on international travel continuing to grow, it would not be possible to hold the event in its current format without impacting on the quality of the sessions.

Please review our cancellation policy below. If you have any questions please email researchevents@cancer.org.uk

Important cancellation information

All cancellations must be made in writing to researchevents@cancer.org.uk. We do not accept telephone cancellations.

All registrants are eligible for a full refund of their ticket. If we do not receive a cancellation email, your booking will automatically be transferred to the rescheduled date. If you are unable to attend the rescheduled meeting, please email researchevents@cancer.org.uk to request a full refund.

Cancer Research UK are not liable for any travel or accommodation costs relating to attendee bookings.

Poster and proffered talks

Once a new date for the conference has been confirmed, we ask you to resubmit your abstract for consideration.

Please note that timings are subject to change 

Tuesday 12 May 2020

 

09.30

Registration/ Poster set up

Tea and coffee

11.00

Welcome

Michelle Monje-Deisseroth, Stanford Universirty
Simona Parrinello, University College London

Richard Gilbertson, Cancer Research UK Cambridge Centre at Cambridge University

11.15

Opening keynote lecture
Sir Peter Ratcliffe

University of Oxford and The Francis Crick Institute

12.15

Networking lunch / Poster session / Exhibition viewing

13.15 

Synaptogenesis and brain cancer

Chair: Frank Winkler, Universität Heidelberg

Speakers:
Michelle Monje, Deisseroth, Stanford University
Shawn Hervey-Jumper, University of California San Francisco 
Ben Deneen, Baylor College of Medicine 
Doug Hanahan, Swiss Institute for Experimental Cancer Research 

Panel discussion

15.25

Networking break / Exhibition viewing

16.15

Tools to manipulate the nervous system

Chair: Jason Lewis, Memorial Sloan Kettering Cancer Center

Speakers:

Paula Hammond, Massachusetts Institute of Technology

William Weiss, University of California San Diego
Simon Walker-Samuel, University College London 

Polina Anikeeva, Massachusetts Institute of Technology

 

Panel discussion

18.05

Networking drinks / Poster session/ Exhibition viewing

19.20

Close  

Wednesday 13 May 2020

08.30

Delegate arrival/ Poster set up

Tea and coffee

09.00

Stem cells and the developmental origins of brain tumours

Chair: Steve Pollard, University of Edinburgh

Speakers:

Peter Dirks, Hospital for Sick Children, Ontario

Luis Parada, Memorial Sloan Kettering Cancer Center, New York City 

Richard Gilbertson, Cancer Research UK Cambridge Centre at Cambridge University

Panel discussion

11.10

Networking break / Exhibition viewing

11.40

Neuro-immunology and therapeutic opportunities

Chair: Silvia Marino, Queen Mary University of London

Speakers:

Karin Straathof, UCL Great Ormond Street Institute of Child Health

Hideho Okada, University of California San Francisco

Dirk Sieger,  University of Edinburgh

Sergio Quezada,  University College London

Panel discussion

13.05

Networking lunch/ Poster session/ Exhibition viewing

14.50

Understanding the microenvironment and new therapeutic opportunities

Chair: Gabriele Bergers, VIB-KU Leuven Center for Cancer Biology

Speakers:

Simona Parrinello, University College London

Adrienne Boire, Memorial Sloan Kettering Cancer Center

Paul Mischel, University of California San Diego & Ludwig Cancer Research Centre

Valerie Weaver, University of California, San Francisco

 

17.00

Networking break / Exhibition viewing

17.30

Session 6: Future Leaders

Chair: Michael Taylor- Hospital for Sick Children

Short talks
 

Lightning talks
 

 

18.35

Networking drinks / Poster session / Exhibition viewing

19.20

Conference dinner

 

Thursday 14 May 2020

08.45

Delegate arrival

Tea and coffee

09.00

Keynote Speaker

Doug Hanahan, Swiss Federal Institute of Technology

 

10.05

Networking break / Exhibition viewing

10.25

Part 1 Biology and ‘Omics for Precision Medicine

Chair: Neil Carragher, University of Edinburgh

Speakers:
Nada Jabado, McGill University
Stefan Pfister, German Cancer Research Center

David Jones, DKFZ, Germany

Rajesh Chopra, The Institute of Cancer Research

Panel discussion

12.35

Networking lunch / Exhibition viewing

13.35

The Great Debate: Early detection will never work in brain tumours 

Speakers:
Chris Jones, The Institute of Cancer Research 

Mark Gilbert, National Cancer Institute

Panel discussion

14.40

Networking lunch / Exhibition viewing

16.15

 Part 2  Biology and ‘Omics for Optimising Efficacy and Reducing Toxicity

Chair: Eric Holland- Fred Hutchinson Cancer Research Center, USA

Speakers:

Mario Suva, Harvard University

Michael Taylor, Hospital for Sick Children

Mariella Filbin, Dana- Farber Cancer Institute

Sven Nelander, Uppsala University Sweden

17:10  CLOSING REMARKS AND POSTER PRIZES 

Contact us

If you need more information on the event please contact us:

researchevents@cancer.org.uk

Sponsors and exhibitors

 

Aurora Callaghan
Research Events Manager
researchevents@cancer.org.uk
Tel +44 (0)203 469 6348

Research opportunities in brain tumours

[Brain icon]

Brain tumour survival remains low, and has changed little in over a generation. That's why we've made brain tumours a strategic priority as one of our four "cancers of unmet need".

We're boosting our investment into brain tumours, and we have a number of opportunities to help you develop your brain tumour research or to apply your skills to these cancers for the first time.